| Protocol Number |
Study Title |
|
CALGB 100104 |
A Phase III Randomized, Double-Blind Study of Maintenance Therapy with
CC-5013 or Placebo Following Autologous Stem Cell Transplantation for Multiple Myeloma
|
|
CTSU E1A06 |
An Intergroup Phase III Randomized Controlled Trial Comparing Melphalan, Prednisone and Thalidomide Versus Melphalan, Prednisone and Lenalidomide in Newly Diagnosed Myeloma Patients Who Are Not Candidates for High-Dose Therapy |
|
SWOG S0120 |
A Prospective Observational Biologic Study of Asymptomatic Patients with Monoclonal Gammopathy and Plasmaproliferative Disorders |
|
SWOG S0334 |
Cytogenetic and Fluorescence In Situ Hybridization Studies in Multiple Myeloma |
|
SWOG S0777 |
A Randomized Phase III Trial of CC-5013 (Lenalidomide) and Low Dose Dexamethasone (LLD) Versus Bortezomib (PS-341), Lenalidomide and Low Dose Dexamethasone (BLLD) for Induction, in Patients with Previously
Untreated Multiple Myeloma Without an Intent for Immediate Autologous Stem Cell Transplant
|
